Jon Gray, president and chief operating officer of Blackstone, one of the world’s leading investment firms, and his wife, Mindy, recently awarded $1.5 million to fund an important collaboration between Dana-Farber and Harvard Medical School aimed at developing non-surgical alternatives for reducing breast cancer risk in women who carry BRCA1 mutations.